This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our
Privacy Policy.
Accept
Gain insight into
research trends
and
influential papers
with
Research Intelligence.
Search everything
Product tour
About us
Our data
Use cases
Pricing
Sign in
Sign up
Home
Research Intelligence
Pro
Expert Finder
Pro
Scinapse Trends
Paper Search
Journal Search
Collections
Favorites
History
Notes
Keyword Alerts
Submit Feedback
Settings
doi.org/10.1007/s40265-018-0987-2
Other
Lanadelumab: First Global Approval
Yahiya Y. Syed
36
View all 1 authors
Drugs
13.00
Volume: 78, Issue: 15, Pages: 1633 - 1637
Published
: Sep 28, 2018
25
Citations
Sources
Cite
Save
Basic Info
Analytics
References
Citations
Abstract
No abstract.
Paper Fields
Linguistics
Receptor
Enzyme
Monoclonal antibody
Bradykinin
Monoclonal
Immunology
Alternative medicine
Kallikrein
Medicine
Philosophy
Shire
Hereditary angioedema
Biochemistry
Internal medicine
Pathology
Placebo
Angioedema
Pharmacology
Antibody
Chemistry
Monoclonal gammopathy
Paper Details
Title
Lanadelumab: First Global Approval
DOI
doi.org/10.1007/s40265-018-0987-2
Published Date
Sep 28, 2018
Journal
Drugs
Volume
78
Issue
15
Pages
1633 - 1637
Notes
To use the Note feature, you need to be logged in. Please
sign in.
History
View all history
Lanadelumab: First Global Approval
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.
Skip
Next